AbbVie Biopharmaceuticals GmbH
Gesellschaft mit beschränkter Haftung (GmbH) · Cham, Switzerland · LEI 5493008JRB6XLN6ZMK73
LEI active
Summary
AbbVie Biopharmaceuticals GmbH is registered in Switzerland and entered in the “Commercial Register” under number CHE-414.545.762. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Switzerland). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 3 of them in Switzerland. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 5 Dec 2012 and the record was last updated on 18 May 2026; the next renewal is due by 18 May 2027. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2020, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Gesellschaft mit beschränkter Haftung (GmbH) private limited company (Switzerland) |
|---|---|
| Register | Commercial Register · Register website |
| Registration number | CHE-414.545.762 |
| Registration authority | Ministry of Justice |
| Jurisdiction | Switzerland |
| Registered address | Alte Steinhauserstrasse 14, 6330 Cham, Switzerland |
| Headquarters address | 1 North Waukegan Road, 60064 North Chicago, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 30 May 2012 |
| LEI | 5493008JRB6XLN6ZMK73 |
| LEI status | active |
| LEI first issued | 5 Dec 2012 |
| LEI record last updated | 18 May 2026 |
| Next LEI renewal | 18 May 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
AbbVie Biopharmaceuticals GmbH this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 1 Jan 2020 to 31 Dec 2020 | 1 Jan 2020 to 31 Dec 2020 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 20 Mar 2018 | 20 Mar 2018 |
| Recorded at GLEIF since | 13 Sep 2021 | 13 Sep 2021 |
| Last updated | 10 Nov 2025 | 10 Nov 2025 |
| Record status | current | current |
Direct subsidiaries (1)
- ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND) Taiwan · Taipei City
Other subsidiaries of the same direct parent (59)
- AbbVie AG Switzerland lapsed
- Pharmacyclics Switzerland GmbH Switzerland
- AbbVie A/S Denmark lapsed
- AbbVie AS Norway lapsed
- AbbVie B.V. Netherlands lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
- ABBVIE BIOTECHNOLOGY LTD Bermuda
- AbbVie Central Finance B.V. Netherlands
- AbbVie Corporation Canada
- ABBVIE D.O.O. Slovenia lapsed
- AbbVie Deutschland GmbH And Co. KG Germany lapsed
- Abbvie Endocrine Inc. United States lapsed
Other names
- AbbVie Pharmaceuticals GmbH · previous name
- AbbVie Biopharmaceuticals LLC · trading name
- AbbVie Biopharmaceuticals Sàrl · trading name